Weekly Funding Opps

NIH

NCI
Imaging Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional)
Standard due dates apply
NCI
Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed)
Applications are accepted by continuous receipt.
NCI
Mentored Research Scientist Development Award (Parent K01 Independent Basic Experimental Studies with Humans Required)
Standard due dates apply
NCI
Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimental Studies with Humans Required)
Standard due dates apply
NIH
PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
Standard due dates apply
NIH
PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
Standard due dates apply
NCI
Imaging Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional)
Standard due dates apply
NCI
Imaging Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional)
Standard due dates apply
NCI
National Cancer Institute Program Project Applications for the Years 2023 2024 and 2025 (P01 Clinical Trial Optional)
LOI due 30 days before application due date
Standard due dates apply
NIH
HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
Standard due dates apply
NIH
Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional)
Standard due dates apply
NCI
Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required)
Standard due dates apply
NCI
Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)
Standard due dates apply
NIH
PHS 2024-2 Omnibus Solicitation of the NIH CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
Standard due dates apply
NIH
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Not Allowed)
Standard due dates apply
NIH
Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)
Application Due: 07/01/25
NCI
DCP Early Career Scientist Opportunity Annual Call for Nominations Now Open
Application Due: 07/31/25

Foundation

Robert A. Winn Diversity in Clinical Trials Award Program
Robert A. Winn Diversity in Clinical Trials: Career Development Award (Winn CDA)
OREF
OREF Research Grants (various)
Society for Immunology of Cancer
2024 SITC-Mallinckrodt Pharmaceuticals Adverse Events in Cancer Immunotherapy Clinical Fellowship
Pew
Pew-Stewart Scholars for Cancer Research
Melanoma Research Foundation
Melanoma Research Foundation RFP (various)
https://melanoma.org/research-science/research-grants/research-grant-rfps/
Alex's Lemonade Stand Foundation
Alex's Lemonade Stand Foundation (ALSF) Grants - various
Deadlines vary by award
American Association for Cancer Research
AACR MINORITY SCHOLAR IN CANCER RESEARCH AWARDS
American Lung Association
American Lung Association (various)
due dates vary -- see application for each award
Lung Cancer research Foundation (LCRF)
LCRF (various)
Gray Foundation
GRAY FOUNDATION BRCA TEAM SCIENCE PROGRAM
Children's Cancer Research Fund (CCRF)
Children's Cancer Research Fund Research Grant (various)
American Cancer Society
Extramural Discovery Science Accelerator Award
Applications submitted through June 1 will be reviewed in July. Applications submitted after June 1 will be reviewed in December. Grants start in September 2025 (July review) or 04/2026 (December)
Colorectal Cancer Alliance
Project Cure CRC
rolling request for proposals
Society for Immunology of Cancer
SITC-Merck Cancer Immunotherapy Clinical Fellowship
Alan B. Slifka Foundation
Sarcoma Research Grants Initiative
send a 1-2 page letter of intent (LOI) to sarcomaLOI@slifkafoundation.org.
American Cancer Society
American Cancer Society Grants (various)
Deadlines April 1 and October 15
St. Baldrick's Foundation
St. Baldrick's Foundation Grants
Memorial Sloan Kettering Cancer Center
Clinical Chemistry Fellowship
Applications will be accepted until the position is filled. Early application is encouraged.
The Hope Foundation
SWOG Trial Support (STrS)
Prostate Cancer Foundation
Prostate Cancer Foundation Awards (Various)
Deadlines vary across grants
Breast Cancer Alliance
Exceptional Project Grants
LOI due: 03/31/2025
American Association for Cancer Research (AACR)
AACR-Novocure Career Development Award for Cancer Research
Application Due: 06/30/25
American Association for Cancer Research (AACR)
AACR-Novocure Cancer Research Grant
Application Due: 06/30/25
Fibrolamellar Cancer Foundation
Fibrolamellar Cancer Foundation Research Grant Program
Application Due: 07/01/25
Patient Centered Outcomes Research Institute
Phased Large Awards for Comparative Effectiveness Research PCORI Funding Announcement -- Cycle 2 2025
LOI due: 05/13/2025
Application Due: 09/03/25

MDH

Maryland Department of Health
MHHD Grant Programs
see each grant for specific deadline

Award

Society for Immunotherapy of Cancer
SITC-MRA Women in Melanoma Fellowship Award

NIH NOSI

NCI
Notice of Special Interest (NOSI): Administrative Supplements for Enhancing Recruitment and Retention of Diverse Populations to Cancer Screening Cancer Prevention and Symptom Management Clinical Trials
Application Due: 07/01/25
NIH
Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers
Application Due: 07/02/25
NIH
Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers
Application Due: 07/02/25
NCI
Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers
Application Due: 07/02/25
NCI
Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers
Application Due: 07/02/25
NCI
Notice of Special Interest: Health Influences of Gender as a Social and Structural Variable
Application Due: 10/01/25
NCI
Notice of Special Interest (NOSI): Pragmatic Trials in Low Resource Settings
Application Due: 11/18/25
NCI
Notice of Special Interest (NOSI): Pragmatic Trials in Low Resource Settings
Application Due: 11/18/25
NIH
Notice of Special Interest (NOSI): Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics
Application Due: 01/08/26
NCI
Notice of Special Interest (NOSI): Telehealth Research in Cancer Care
Application Due: 03/17/26
NCI
Notice of Special Interest (NOSI): Epidemiologic Studies to Assess the Impact of Incretin Mimetics on New and Recurrent Cancer Risk
Application Due: 05/09/26
NCI
Notice of Special Interest (NOSI): Epidemiologic Studies to Assess the Impact of Incretin Mimetics on New and Recurrent Cancer Risk
Application Due: 05/09/26
NIH
Notice of Special Interest (NOSI): Addressing Health Disparities Among Immigrant Populations Through Effective Interventions
Application Due: 06/06/26
NIH
Notice of Special Interest (NOSI): Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations
Application Due: 06/06/26
NCI
Notice of Special Interest (NOSI): Research on HIV-associated Malignancies
Application Due: 09/08/26
NCI
Notice of Special Interest (NOSI): Assessing Real-World Effectiveness and Implementation of Telehealth-Guided Provider-to-Provider Communication among Rural Communities
Application Due: 10/10/26
NCI
Notice of Special Interest (NOSI): Assessing Real-World Effectiveness and Implementation of Telehealth-Guided Provider-to-Provider Communication among Rural Communities
Application Due: 10/10/26
NIH
Notice of Special Interest (NOSI): Promoting Data Reuse for Health Research
Application Due: 11/04/26
NCI
Notice of Special Interest (NOSI): Exploratory Cancer Immunology Projects and Technologies (ExCITe)
Application Due: 11/17/26
NIAID
Notice of Special Interest (NOSI): Development of Organotypic Culture Models for Transplantation Immunology Research
Application Due: 11/17/26
NCI
Notice of Special Interest (NOSI): National Cancer Institute Entrepreneurial Education Programs to Facilitate Commercialization of Cancer Relevant Technologies
Application Due: 01/08/27
NCI
Notice of Special Interest (NOSI): Quantum Sensing Technologies in Biomedical Applications
Application Due: 01/27/27
NIH
Notice of Special Interest (NOSI): Quantum Sensing in Biomedical Applications (SBIR/STTR)
Application Due: 01/27/27
NCI
Notice of Special Interest (NOSI): Chronic Inflammation of the Oral Cavity - An Agent for Oral Mucosal Disease
Application Due: 05/10/27
NIH
Notice of Special Interest (NOSI): Improving Adherence to Treatment and Prevention Regimens and Maintenance of Health Behaviors to Promote Health
Application Due: 07/14/27
NCI
Notice of Special Interest (NOSI): Research Projects to Develop Oncoaging Models for Cancer Research
Application Due: 07/31/27
NCI
Notice of Special Interest (NOSI): Developing and Testing Multi-level Physical Activity Interventions to Improve Health and Well-Being
Application Due: 11/14/27
NIH
Notice of Special Interest (NOSI): Communication and Decision-Making in a Complex and Dynamic Cancer Treatment Environment
Application Due: 09/08/28
NCI
Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Control and Population Sciences
Application Due: 05/08/29
NCI
Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Control and Population Sciences
Application Due: 05/08/29
NCI
Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Prevention
Application Due: 05/08/29
NCI
Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Prevention
Application Due: 05/08/29